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Abstract
: The role of structural and functional abnormalities of small vessels in diabetes cardiomyopathy
remains unclear. Myocardial contrast echocardiography allows the quantification of myocardial
blood flow at rest and during dipyridamole infusion. The aim of the study was to determine the
myocardial blood flow reserve in normal rats compared with Streptozotocin-induced diabetic rats
using contrast echocardiography.
Methods:  We prospectively studied 40 Wistar rats. Diabetes was induced by intravenous
streptozotocin in 20 rats. All rats underwent baseline and stress (dipyridamole: 20 mg/kg) high
power intermittent imaging in short axis view under anaesthesia baseline and after six months.
Myocardial blood flow was determined and compared at rest and after dipyridamole in both
populations. The myocardial blood flow reserve was calculated and compared in the 2 groups.
Parameters of left ventricular function were determined from the M-mode tracings and histological
examination was performed in all rats at the end of the study.
Results: At six months, myocardial blood flow reserve was significantly lower in diabetic rats
compared to controls (3.09 ± 0.98 vs. 1.28 ± 0.67 ml min-1 g-1; p < 0.05). There were also a
significant decrease in left ventricular function and a decreased capillary surface area and diameter
at histology in the diabetic group.
Conclusion:  In this animal study, diabetes induced a functional alteration of the coronary
microcirculation, as demonstrated by contrast echocardiography, a decrease in capillary density
and of the cardiac systolic function. These findings may offer new insights into the underlying
mechanisms of diabetes cardiomyopathy.
Published: 2 September 2008
Cardiovascular Diabetology 2008, 7:26 doi:10.1186/1475-2840-7-26
Received: 7 July 2008
Accepted: 2 September 2008
This article is available from: http://www.cardiab.com/content/7/1/26
© 2008 Cosyns et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Cardiovascular Diabetology 2008, 7:26 http://www.cardiab.com/content/7/1/26
Page 2 of 10
(page number not for citation purposes)
Introduction
Diabetic cardiomyopathy is known to develop in humans
in the absence of coronary or hypertensive disease [1]. The
mechanism by which diabetic cardiomyopathy develops
has been studied in literature using in vivo and ex vivo
experiments [2,3]. It has been postulated that endothelial
dysfunction, endomyocardial fibrosis, direct toxic effect of
hyperglycemia on cardiomyocytes and autonomic neu-
ropathy play an important role. Although recent studies
have suggested abnormalities in coronary small vessels in
humans [4,5], similar to dilated cardiomyopathy [6,7],
and in spontaneously diabetic rats [8], the association
between vascular and myocardial disease in diabetes
remains controversial.
Myocardial contrast echocardiography (MCE) has been
shown to be a useful tool to estimate the myocardial
blood flow (MBF) at rest and during stress in dogs and
humans [9-13]. Echocardiography has been recently
adapted to image hearts of rodents [14] and MCE has
shown a good correlation of MBF estimates with micro-
spheres technique [15].
In order to better investigate the role of functional vessel
abnormalities and its relationship with structural small
vessel abnormalities, we sought to apply this new MCE
method in a small animal model of Streptozotocin-
induced diabetes, to determine the coronary vascular
reserve compared to normal controls, combined with his-
topathology. Furthermore, we aimed to establish a rela-
tionship between these alterations and the cardiac
function.
Methods
Animals handling and study protocol
A total of 40 adult male Wistar Unilever rats (Harlan, The
Netherlands) (10 weeks-old, 328 ± 7 g) were studied.
Diabetes mellitus was induced in 20 rats by a single intra-
venous injection of 45 mg/kg Streptozotocin (STZ) in a
0.1 mol/l citrate buffer solution. Three days after treat-
ment with STZ, tail vein blood glucose samples were
measured with OnetouchR glucometer (Johnson & John-
son) to ensure induction of diabetes. During the entire
study the animals were housed in stainless steel cages with
sawdust bedding. They were kept at an average room tem-
perature of 24°C, a relative humidity of 50% and a 12-
hour day/night cycle. All rats had unlimited access to food
and water during follow up.
MCE was performed at 1 and 6 months, both at rest and
after dipyridamole (DIP) infusion (20 mg/kg over 10
minutes). Blood pressure was measured with the
advanced auto-inflate blood pressure monitor with infra-
red sensor and tail-cuff from Harvard Apparatus® France.
The rats were anesthetized with pentobarbital 50 mg/kg
intraperitoneally and allowing spontaneous respiration.
This study was approved by the Animal Research Commit-
tee at the Vrije Universiteit Brussel and conformed to the
Institute for Laboratory Animal Research Guide for Care
and Use of Laboratory Animals.
Myocardial Contrast Echocardiography
The anterior chest hair was removed with a shaver and the
rats were positioned in left lateral decubitus on a wooden
bench. Recordings were made under continuous ECG
monitoring by fixing electrodes on the paws. A 24-gauge
cannula was inserted into a tail vein for infusion. The
commercially available contrast agent Sonovue® (Bracco
Diagnostics, Inc.) is an aqueous suspension of stabilized
SF6  microbubbles. The size of these microbubbles is
between 1 and 10 μm, and their number is between 2 and
5 × 108 per mL. The solution was prepared according to
the manufacturer's instructions. Subsequently this solu-
tion was diluted twice by adding 5 ml of sodium chloride
0.9% (same carrier fluid). A continuous infusion of the
diluted solution of Sonovue® was given using a dedicated
pump (Bracco, Italy) at a rate of 0.3–0.4 ml/min.
We used a Vivid 7 (GE, VingMed, Horton, Norway) with a
10 MHz (10S) probe. High power intermittent images
were recorded in a parasternal short axis view at a depth of
2 cm at the level of the papillary muscles. The transmit
power was set at a maximum (0 dB), with a mechanical
index of 0.8. Gain settings were optimized at the begin-
ning of the study and subsequently held constant. The
pulsing interval (PI) was gated to the ECG (end systole)
and progressively increased from 1 to 20 (depending on
the heart rate). Images were digitally stored and measure-
ments were analysed offline by the cardiologist, using the
EchoPAC software (GE Vingmed, version 3.1.3). Regions
of interest were placed on the anterior myocardium with
a constant size (height: 1 mm, wide: 3 mm). The myocar-
dial ROIs were individually adjusted by hand to carefully
avoid the right and LV cavities. Videointensity (VI) was
measured in these ROI's. As shown in the Figure 1, PI ver-
sus background-substracted images VI plots were then
generated, and they were fitted to the exponential func-
tion y = A(1-e-βt), in which beta represents the rate of rise
in signal intensity, which reflects microbubble velocity,
and A is the peak plateau amplitude, which reflects the
microvascular cross-sectional area or myocardial blood
volume, as previously described [16]. Regional differences
in VI due to concentration of microbubbles in blood may
occur and the same concentration may not be achievable
both at rest and during stress even with continuous infu-
sions. Moreover, significant heterogeneity of acoustic
energy in different parts of the scan sector makes compar-
isons of backscatter signals from segments at the marginsCardiovascular Diabetology 2008, 7:26 http://www.cardiab.com/content/7/1/26
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or lower depths difficult with those in the centre and
attenuation also results in spurious decreases in myocar-
dial VI. Therefore, we quantitatively estimated the relative
blood volume rBV by the division of myocardial plateau
video intensity A and the adjacent left ventricular intensity
in the near wall cavity (ALV), as described previously [12].
In accordance with Positron Emisson Tomography, at was
set to 1.05 g·ml-1, and MBF was calculated with the fol-
lowing equation: MBF = rBV × β/ρT = (A-ALV) × β/ρT
Finally, the vasodilator reserve for beta and rBV, MBF,
were calculated as the ratio of hyperaemic to baseline val-
ues for these parameters.
Echocardiographic measurements
Grey scale images were recorded in a parasternal short axis
view at a depth of 1.5 to 2 cm, using a linear 13 MHz
probe (i13L), both at rest and after dypiridamole infu-
sion. Left ventricular chamber diameter in end-systole
(LVESD) and end-diastole (LVEDD), left ventricular ante-
rior wall thickness in end-systole and end-diastole, and
left ventricular posterior wall thickness in end-systole and
end-diastole, as well as left ventricular fractional shorten-
ing (FS% = [(LVEDD – LVESD)/LVEDD] × 100), were
determined from the M-mode tracings in a short axis view
(average of three consecutive cycles) at the level of the
papillary muscles.
Histology
At the end of the follow-up, all rats were killed with with
2 ml/kg sodium pentobarbital (CEVA, Brussels, Belgium)
intravenously for histological studies. The hearts were
immediately removed and fixed in 4% neutral buffered
formalin for 2 hours. Three short-axis slices of myocardial
tissue were obtained and embedded in paraffin. Heama-
toxylin-eosin and Masson's trichrome staining were per-
formed. Morphometry was performed by digital image
analysis using a PC digital image camera (Digital Sight
DS-5M, Nikon Corp, Japan) mounted on an Axiolab Zeiss
light microscope (Carl Zeiss Corp, Germany) with a 10×
objective (Acroplan, Zeiss). We used the NIH Image pro-
gram (Image-J 1.35d, Nation Institutes of Health,
Bethesda, USA). The program was calibrated with a grad-
uated slide. Five randomly selected Masson's Trichrome
microscopic images were used to evaluate the cardiomyo-
cytes, interstitium and capillaries. The width of at least 10
left ventricle cardiomyocytes was measured in each sec-
tion. Colour segmentation was applied to calculate the
Example of quantitative perfusion analysis Figure 1
Example of quantitative perfusion analysis. The rBV was quantitatively estimated by the division of myocardial plateau 
video intensity and the adjacent left ventricular intensity in the near wall cavity at rest and during hyperaemia (DIP).
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percentage of interstitial fibrosis. For the measurement of
the capillary surface the histological photomicrographs
were converted to 8-bit grey scale images. Subsequently,
the threshold was adjusted until only the space between
the cardiomyocytes was highlighted. This space was con-
sidered as a marker for capillary area. The percentage of
black colored area was then measured. (Figure 2) Capil-
lary diameters were measured manually. Microangiopa-
thy involving arterioles, capillaries, and venules, and
hyaline arteriosclerosis were also evaluated. An experi-
enced pathologist performed the analyses blindly.
Statistical analysis
Data are expressed as mean ± SD. The unpaired Student's
t test was used for continuous variables to assess differ-
ences between groups, whereas ordinal variables were
analyzed with the chi-square test. A subset of 10 rats
underwent MCE three days after the first examination in
order to test the interstudy variability. Differences
between the repeated measurements were evaluated by
the paired Student's t-test. The coefficient of variability
was expressed as the percentage difference for each pair of
measurements as ((measurement observation 1 – meas-
urement observation 2)/0.5 × (measurement observation
1+ measurement observation 2)) × 100 and expressed as
mean ± SD. Another subset of 20 rats studies (10 rest and
10 stress) were analyzed by two independent observers,
blinded for the results of each other, in order to test the
interobserver variability. The interobserver variability in
quantitative MCE was assessed by computing intraclass
correlation coefficients using one-way ANOVA with a ran-
dom factor and by calculating the limits of agreement
between measurements made by use of Bland-Altman
analysis [17]. A value of p < 0.05 was considered statisti-
cally significant. All statistical analyses were performed
using SPSS (version 14.0) statistical software (SPSS Inc,
Chicago, IL).
Results
Clinical parameters
Glucometry and gravimetric parameters are summarized
in Table 1. After six months, animals treated with STZ had
high glucose levels. Other symptoms frequently associ-
ated with diabetic state such as lower body weights, poly-
uria, polyphagia were observed in the diabetic rats. The
heart mass decreased in the diabetic group but it was not
Histological characteristics and analysis of the myocardium in the diabetic and control rats after 20 weeks Figure 2
Histological characteristics and analysis of the myocardium in the diabetic and control rats after 20 weeks. Top 
panel (A), Masson's trichrome staining showed no evidence of myocardial fibrosis in both groups. Cardiomyocytes were 
smaller in the diabetic animals (upper right). Lower panel (B), the histological photographs (A) were subsequently converted to 
8-bit grey scale images (not shown) and an appropriate threshold was chosen in order to visualize the capillaries only (black 
and white images, B). The percentage capillary area and capillary diameters were lower in the diabetic rats compared to con-
trols (lower right). Magnification at 400× (A and B), scale bar is 100 μm, *P < 0.05.Cardiovascular Diabetology 2008, 7:26 http://www.cardiab.com/content/7/1/26
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significant compared to controls. The heart/body weight
ratio significantly increased in the diabetic group.
At the end of the follow-up there was no significant
change in heart rate in the diabetic when compared to
control rats nor in systolic blood pressure.
Myocardial contrast echocardiography
Simple pulsing sequence during MCE was feasible in rats
and it could assess myocardial blood velocity and volume
separately, and myocardial blood flow as the product of
the two. As shown in Table 2, during hyperaemia the basic
haemodynamic parameters did not differ significantly in
both groups. The myocardial blood flow estimate by MCE
was also similar in controls and diabetics at rest and dur-
ing hyperaemia. Interestingly, the β slope was signifi-
cantly less steep in the control group compared to
diabetics, both at rest and during hyperaemia. Although
relative blood volume was not different at baseline in
both groups, the rBV had significantly increased with
hyperaemia in the controls compared to diabetics. Table 3
summarizes the changes in perfusion parameters and the
myocardial perfusion reserve with hyperaemia. Although
diabetics had a steeper β slope at rest and during hyperae-
mia, the change in β did not differ significantly between
controls and diabetics. Conversely, changes in rBV were
significantly more pronounced in the controls than in dia-
betics. As a result, the myocardial perfusion reserve was
significantly higher in the control group.
Finally, no side effects due to contrast were observed and
there was no significant change of the heart rate before
and after contrast infusion both at rest and during hyper-
aemia.
Interobserver and interstudy variability
Measurements were obtained in all rats. In the subset of
10 rats in which MCE was performed three days after the
first examination in order to test the interstudy variability,
differences between the repeated measurements were not
statistically significant (p > 0.05). Interobserver variability
was acceptable: 13.2 ± 10.1% and 14.5 ± 4.5% for top A
and slope β, respectively. Bland-Altman analysis showed a
good agreement between observers for both rest and DIP
studies, as shown in the Figure 3.
Echocardiographic measurements
Means and SD of the different anatomical parameters are
given in Table 4. As can be derived from the M-Mode
measurements, there was no difference between normal
and diabetic rats after six months of follow-up both at rest
and during DIP infusion, except for a decrease in inferior
wall thickness at rest in diastole. When corrected for LV
mass [18], a significant increase in LVESD (6.13 ± 1.8 vs
3.98 ± 0.03 mm/g; p < 0.001) and in LVEDD (13.98 ± 1.4
vs 5.12 ± 0.02 mm/g; p < 0.001) was observed in the dia-
betic group compared to controls.
Histology
There was no difference regarding extra-cellular collagen
deposits (trichrome staining) or endomyocardial necrosis
(heamatoxilin-eosin staining) in myocardium of control
and diabetic rats at the end of the follow up. The percent-
age of fibrosis was less than 1%, with no difference
Table 1: Glucometry and gravimetric data obtained at 6 months of diabetes
Glycemia (mg/dL) Body mass (g) Heart mass (mg) Heart to Body Mass ratio (mg/g)
Controls (n = 20) 95 ± 13 662 ± 49 1369 ± 222 2.1 ± 0.2
Diabetics (n = 20) 426 ± 54* 382 ± 34* 1182 ± 279 2.8 ± 0.3*
*p < 0.05
Table 2: Haemodynamic and perfusion data at baseline and during hyperaemia in controls and diabetics.
Baseline Hyperemia
Variable Controls Diabetics p Controls Diabetics p
Heart rate, min-1 318 ± 27 299 ± 33 NS 315 ± 29 316 ± 25 NS
SBP, mm Hg 131 ± 7 131 ± 13 NS 96 ± 3 100 ± 6 NS
RPP, min-1 mm Hg 41,342 ± 1,234 39,056 ± 1,324 NS 31,339 ± 1,567 31,561 ± 1,234 NS
MBF, ml·min -1·g -1 2.42 ± 0.823 3.75 ± 0.943 NS 5.81 ± 0.99 5.02 ± 0.76 NS
β, min-1 23.3 ± 8.2 27.6 ± 9.1 † 32.3 ± 7.7 37.4 ± 9.9 †
rBV, ml·min -1 0.112 ± 0.045 0.120 ± 0.05 NS 0.191 ± 0.046 0.141 ± 0.043 *
Values are mean ± SD. *p = 0.0001; †p = 0.005.
MBF = myocardial blood flow; rBV = relative blood volume;
RPP = rate-pressure product; SBP = systolic blood pressure.Cardiovascular Diabetology 2008, 7:26 http://www.cardiab.com/content/7/1/26
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between the two groups at the end of the follow up. Mean
capillary surface area (16.2 ± 1.7%, p = 0.01) and capillary
diameter (11.9 ± 0.5 μm, p = 0.04) were significantly
lower in the diabetic animals compared to the controls
(11.0 ± 1.2% and 10.8 ± 0.3 μm, respectively). No micro-
angiopathy involving arterioles, capillaries, venules, and
hyaline arteriosclerosis was observed.
Discussion
The study of cardiomyopathies in small animals may con-
tribute to our understanding of the cardiac pathophysiol-
ogy and to evaluate experimental treatment strategies. The
present study shows that myocardial perfusion imaging
with contrast echocardiography can successfully be
applied for the non-invasive evaluation of cardiac per-
fusion at rest and under hyperaemia in STZ-induced dia-
betic rats. Our results suggest that after six months,
diabetes induces a functional alteration of the myocardial
microcirculation that may explain left ventricular systolic
dysfunction. Our data further indicate that microcircula-
tion is already altered at rest and that the major determi-
nant for decreasing myocardial perfusion reserve during
Table 3: Changes in perfusion parameters and myocardial 
perfusion reserve with hyperaemia
Changes with Hyperaemia
Variable Controls Diabetics p
MBF, ml·min-1·g -1 3.09 ± 0.98 1.28 ± 0.67 †
β, min-1 9.1 ± 1.2 9.5 ± 1.1 0.06
rBV, ml·ml-1 0.073 ± 0.015 0.023 ± 0.009 *
MPR 2.39 ± 0.89 1.38 ± 0.43 †
Values are mean ± SD. *p = 0.0001;
†p = 0.005. MBF = myocardial blood flow; rBV = relative blood 
volume; MPR = myocardial perfusion reserve
Bland-Altman graphs for top (A) and slope (β) at rest and after dypiridamole in normal rats Figure 3
Bland-Altman graphs for top (A) and slope (β) at rest and after dypiridamole in normal rats. All measurements 
are within 2 SD of their differences demonstrating the agreement between the two independent observers.Cardiovascular Diabetology 2008, 7:26 http://www.cardiab.com/content/7/1/26
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hyperaemia, is the lower capillary recruitment in the dia-
betic group. Finally, histopathology findings demonstrate
a reduced density of myocardial capillaries, in the diabetic
group that can only be unmasked with hyperaemia using
MCE.
Clinical parameters
The STZ induced diabetic rats used in our experiments are
reminiscent of a model of uncontrolled hyperglycemia
due to the direct pancreatic beta cell destruction and
resulting insulin deficiency [19]. Our glucometry and
gravimetric values (Table 1) are in accord with other pub-
lished values at similar time points [20-22]. These STZ rats
resembled more type 1 diabetes. The dose of STZ injected
(45 mg/kg) was low in this study. However, it has been
successfully applied in previous studies [3,14] and the
impact on glucometry and gravimetric values was similar
compared to the administration of a higher dose of STZ,
leading to equivalent absolute insulin deficiency.
Myocardial perfusion
Microbubbles are excellent tracers of red blood cell kinet-
ics. They are pure intravascular tracers. The method to
quantify MBF is based on rapid destruction of these
microbubbles by ultrasound, and subsequent assessment
of the rate of replenishment into the myocardium within
the ultrasound beam elevation. This method allows the
assessment of the components of MBF: flow velocity and
myocardial blood volume [13]. In the presence of
increased myocardial oxygen demand, there is arteriolar
vasodilation, reducing the resistance at the arteriolar level,
which enables a higher precapillary pressure, translating
into increased red blood cell velocity across the capillary
network, and opening dormant capillary networks in
order to maintain mean trans-capillary pressure (recruit-
ment), thus increasing the overall myocardial blood vol-
ume. Hence overall myocardial blood flow is increased.
The present study has shown that quantitative MCE is a
robust method to assess the myocardial blood flow in
small animals at rest and during hyperemia. The measure-
ments are feasible and repeatable over time and between
observers. As expected from physiology and previous in
vitro and in vivo studies [9,10,13,23,24], we were able to
show the increase of MBF with hyperemia in normal rats.
Moreover, our data were consistent with previous experi-
ments in small animals, validating MCE measurements
using microspheres [15].
In our diabetic population, we could observe, at rest, a sig-
nificant increase in β compared to controls. This suggests
a decrease in arteriolar resistance and vasodilation of arte-
rioles. Although this increase in red cell velocity at rest
compared to controls persists under hyperaemia in the
diabetics versus the controls, the change in β is not signif-
icantly different in diabetics compared to controls. This
finding suggests the capacity of arterioles to further
vasodilate, even in the diabetic group, in the absence of
coronary artery lesions.
Structural alterations of the small vessels in diabetes have
been incriminated in the development of diabetic cardio-
myopathy, although this remains controversial. A reduc-
tion in capillary density and a significantly greater
thickening of the capillary basement membrane has been
shown compared to control subject in humans [25] and
more recently in rodents [26]. Because rBV represents
essentially capillaries, one would therefore expect to find
a decrease in A in the diabetic rats, which is not the case at
rest. However, during hyperaemia, there is less increase of
rBV in diabetic rats compared to normal rats, indicating a
less important capillary recruitment in diabetics. This may
reflect the absence of compensation to an increased pre-
capillary pressure mediated by arteriolar vasodilatation,
as shown by the increased red cell velocity at rest and dur-
Table 4: M-Mode parameters of the LV (parasternal short-axis view) measured in normal (n = 20) and diabetic rats (n = 20) after six 
months at rest and after dypiridamole infusion (DIP).
Normal Rest Diabetes Rest Normal DIP Diabetes DIP
Anterior wall diastole (cm) 0.21 ± 0.04 0.19 ± 0.04 0.21 ± 0.02 0.19 ± 0.02
Inferior wall diastole (cm) 0.21 ± 0.03 0.14 ± 0.03* 0.2 ± 0.02 0.18 ± 0.02
Anterior wall thickening (%) 49 ± 17 47 ± 15 58 ± 16 56 ± 16
Inferior wall thickening (%) 48 ± 16 46 ± 14 48 ± 12 49 ± 17
LV enddiastolic diameter (cm) 0.83 ± 0.09 0.88 ± 0.05 0.81 ± 0.07 0.85 ± 0.05
LV endsystolic diameter (cm) 0.47 ± 0.08 0.52 ± 0.05 0.48 ± 0.06 0.51 ± 0.05
LV enddiastolic volume (ml) 1.24 ± 0.3 1.49 ± 0.2 1.12 ± 0.3 1.30 ± 0.22
LV endsystolic volume (ml) 0.29 ± 0.12 0.34 ± 0.08 0.24 ± 0.08 0.28 ± 0.06
Fractional shortening (%) 41.42 ± 4.40 41.19 ± 3.92 40.4 ± 2.94 40.47 ± 3.48
LV ejectionfraction (%) 75.22 ± 4.93 74.86 ± 4.21 78.69 ± 3.01 78.71 ± 3.41
Left ventricular mass (g) 1.35 ± 0.21 1.22 ± 0.28 1.34 ± 0.17 1.23 ± 0.22
* indicates p < 0.05Cardiovascular Diabetology 2008, 7:26 http://www.cardiab.com/content/7/1/26
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ing hyperaemia compared to controls. In our study, his-
topathology did confirm a significant reduction in
capillary density, in accordance with the previous studies
[25,26]. The increase in pre-capillary pressure induced by
the arteriolar vasodilation and the decrease of capillary
density may be compensated by a capillary recruitment at
rest in the diabetic group resulting in no significant
change of rBV. We can hypothesize that hyperaemia is
required to unmask the decrease of capillary density in
diabetics, using MCE. As a net result, myocardial per-
fusion reserve is altered and may lead to relative ischemia.
Similarly, a reduction of myocardial blood flow and sig-
nificant increase in total coronary resistance during hyper-
aemia and consequent impairment of coronary flow
reserve have been reported in type I young adult diabetic
patients with no or minimal microvascular complications
and without any evidence of coronary heart disease [27].
Reduced myocardial flow reserve may lower the threshold
for myocardial ischemia, particularly when coronary sten-
oses are present. It has been proposed that diabetic cardi-
omyopathy is a consequence of repeated episodes of
myocardial ischemia resulting from these functional
abnormalities in small vessels during increased myocar-
dial demand. As shown by Litwin and colleagues, a real
insulin-therapy that aims to normalize the glycemia, also
corrects the cardiac abnormalities [28]. An ongoing study
investigates the effect of the correction of diabetes condi-
tion on the impairment of coronary circulation.
Left ventricular function
There remains controversy regarding diabetes-induced LV
dysfunction, especially in type 1 diabetes, in the absence
of documented coronary artery disease. Some authors
have been able to detect early systolic LV dysfunction and
dilatation of the left ventricle in STZ induced diabetic car-
diomyopathy [29,30]. On the contrary, others were not
able to demonstrate a remodelling and a significant alter-
ation of the systolic function in a similar rat population
[31]. A recent study in patients with type 1 diabetes, even
with the application of echocardiography, biochemical
and morphologic techniques, failed to demonstrate that
diabetes type 1 may actually precipitate myocardial dys-
function and no heart-specific, histological changes in the
myocardium were found. However, as acknowledged by
the authors of this latter study, all the patients were treated
with intensive insulin therapy [32].
Standard measurements of LV wall thickness and systolic
and diastolic LV diameters by M-mode have extensively
been described in normal and diseased rat models [33-
36]. The ratio data such as fractional shortening and ejec-
tion fraction have been demonstrated to be similar in rat
and human echocardiography [36]. Comparable results
were obtained in the present study. In literature anatomi-
cal M-Mode and bi-dimensional echocardiography have
been able to detect early systolic LV dysfunction and dila-
tation of the left ventricle in STZ induced diabetic cardio-
myopathy [22,29,37-39]. We observed an increase in
mean normalized EDV of the diabetic group compared to
controls. Meanwhile the normalized ESV of the diabetic
rats also increased compared to controls but in lower pro-
portion. The significant increase of normalized EDV with
diabetes in this study is in accordance with previous
reports [22,29,40,41]. However, in contrast to our find-
ings, other authors have shown no significant change or
even an decrease in this parameter [42-44]. We also
observed an increase in normalized ESV, suggesting a
decrease in contractility, in accord with all previous stud-
ies [22,29,40,43,44]. The differences in LV volumes may
be due to the method used to normalize the data or to the-
absence of normalization to body weight in other studies.
Allometric relations exist between cardiac and body size
measurements. However, the correct method to use in rat
is unknown. We normalized LV mass to bodyweight as
applied in the previous studies using the same animal
model [22,41]. In addition, these differences may reflect
the difference in the strain of rats (Wistar Unilever, Wistar
Kyoto, Sprague-Dawley), since this factor has been shown
to clearly influence cardiomyopathy in the STZ model of
diabetes [45].
Histopathology
In the present study, no significant pathological changes
were observed in diabetic rats, regarding extra-cellular col-
lagen deposits, endomyocardial necrosis in myocardium,
and no microangiopathy involving arterioles, capillaries,
venules, and hyaline arteriosclerosis was present, at the
end of the follow up. Conversely, in our study, histopa-
thology did confirm a significant reduction in capillary
density. These results are in accordance with previously
published works [25,26]. The muscular fibers were thin-
ner in the diabetic rats: 14.6 ± 3.1 μm in controls and 11.4
± 2.8 μm in diabetics (P = 0.043). This last finding was
also consistent with previously published work (23).
Limitations
Our STZ model resembled more type 1 diabetes and there-
fore, our results may not be applied to other forms of dia-
betes. Using M-Mode, we have only performed radial
measurements of diameters and therefore volumes were
calculated based on these measurements. However, it has
been previously shown that M-mode echocardiographic
measurements are representative of ventricular function
and volumes measurements, compared to other imaging
techniques [3,43]. No significant structural abnormalities
were noted in the myocardium after 6 months. However,
electron microscopic was not performed in the present
study and previous studies using this method have repeat-
edly documented that diabetes is indeed associated with
abnormalities in myocardial structure [46]. This may par-Cardiovascular Diabetology 2008, 7:26 http://www.cardiab.com/content/7/1/26
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tially explain the left ventricular dysfunction despite the
absence of abnormal findings at histology in our study.
Conclusion
Myocardial perfusion imaging with contrast echocardiog-
raphy can successfully be applied for the non-invasive
evaluation of cardiac perfusion at rest and under hyperae-
mia in STZ-induced diabetic rats. After six months, diabe-
tes induces a functional alteration of the myocardial
microcirculation and a left ventricular systolic dysfunc-
tion. Microcirculation is already altered at rest. The major
determinant for decreasing myocardial perfusion reserve
during hyperemia, is the lower capillary recruitment in the
diabetic group. Histopathology findings demonstrate a
reduced density of myocardial capillaries in the diabetic
group that can only be unmasked with hyperaemia using
MCE. These findings may offer new insights into the
underlying mechanisms of diabetes cardiomyopathy.
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